Funding early detection to save lives from pancreatic cancer—faster.
0%
5-Year Survival Rate
0%
Diagnosed Too Late for a Cure
0
New Cases in 2024
0
Deaths in 2024
In almost 9 out of 10 cases, Pancreatic cancer is detected too late for effective treatment.
PRECEDE is building a global early detection network to reverse those odds for good.
What makes PRECEDE different?
PRECEDE unites leading researchers from multiple prestigious institutions and industry partners.
PRECEDE is the only global, open, and collaborative initiative, enabling potentially faster impact than “closed” projects.
PRECEDE bridges the deadly gap between innovative discoveries and lifesaving treatment.
By making a donation to the PRECEDE Foundation, you become a vital part of the movement driving change. Together, we can make a difference and create a future where pancreatic cancer is not only detectable early but also preventable. Your donation allows us to have a meaningful impact on the lives of those affected by pancreatic cancer.
Envisioning A Future Without Pancreatic Cancer
Join us at the 2026 PRECEDE Annual Gala as we honor PRECEDE Founder Dr. Diane Simeone and celebrate her visionary leadership in transforming the future of pancreatic cancer early detection. Together, we will recognize the progress, collaboration, and hope driving this critical work forward. Sponsorship and silent auction opportunities are now available.